Johnson CS - Search Results

1

Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor.

Johnson CS, Chang MJ, Braunschweiger PG, Furmanski P. Johnson CS, et al. J Natl Cancer Inst. 1991 Jun 19;83(12):842-8. doi: 10.1093/jnci/83.12.842. J Natl Cancer Inst. 1991. PMID: 2061944

2

Differential effect in vitro of tumor necrosis factor-alpha (TNF) on normal and virus-infected erythroid progenitors from Friend virus (FVA)-infected mice.

Chang MJ, Pourbohloul SC, Yu WD, Furmanski P, Johnson CS. Chang MJ, et al. Among authors: johnson cs. Exp Hematol. 1992 Dec;20(11):1271-7. Exp Hematol. 1992. PMID: 1337323

3

Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.

Johnson CS, Pourbohloul SC, Furmanski P. Johnson CS, et al. Exp Hematol. 1991 Feb;19(2):101-5. Exp Hematol. 1991. PMID: 1991491

4

Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system.

Johnson CS, Chang MJ, Thurlow SM, Pourbohloul SC, Furmanski P. Johnson CS, et al. Cancer Res. 1990 Sep 1;50(17 Suppl):5682S-5686S. Cancer Res. 1990. PMID: 2117483

5

The effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumours.

Braunschweiger PG, Johnson CS, Kumar N, Ord V, Furmanski P. Braunschweiger PG, et al. Among authors: johnson cs. Br J Cancer. 1990 Jan;61(1):9-13. doi: 10.1038/bjc.1990.4. Br J Cancer. 1990. PMID: 2297494 Free PMC article.

6

Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole.

Braunschweiger PG, Kumar N, Constantinidis I, Wehrle JP, Glickson JD, Johnson CS, Furmanski P. Braunschweiger PG, et al. Among authors: johnson cs. Cancer Res. 1990 Aug 1;50(15):4709-17. Cancer Res. 1990. PMID: 2369744

7

Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.

Braunschweiger PG, Johnson CS, Kumar N, Ord V, Furmanski P. Braunschweiger PG, et al. Among authors: johnson cs. Cancer Res. 1988 Nov 1;48(21):6011-6. Cancer Res. 1988. PMID: 3262418

8

Antitumor activity of interleukin-1 alpha and cisplatin in a murine model system.

Grandis JR, Chang MJ, Yu WD, Johnson CS. Grandis JR, et al. Among authors: johnson cs. Arch Otolaryngol Head Neck Surg. 1995 Feb;121(2):197-200. doi: 10.1001/archotol.1995.01890020059012. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7840928

9

Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.

Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS. Chang MJ, et al. Among authors: johnson cs. Cancer Res. 1994 Oct 15;54(20):5380-6. Cancer Res. 1994. PMID: 7923169

10

Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.

Johnson CS, Chang MJ, Yu WD, Modzelewski RA, Grandis JR, Vlock DR, Furmanski P. Johnson CS, et al. Cancer Chemother Pharmacol. 1993;32(5):339-46. doi: 10.1007/BF00735916. Cancer Chemother Pharmacol. 1993. PMID: 8339383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

562 results

Search Page

Filters